VCR ventracor limited

fair value 70 cents, page-2

  1. 1,182 Posts.
    Obviously you dont have much knowledge about the market of LVAD's. Upwards of 50,000 patients per year growing at a rate of 10% per year.....times that by $100,000 per device and there's your market.

    Sure there are a few companies in this field but they cant sustain the demand now. Only 2,000 heart transplants per year in the US alone shows that the demand for another alternative is needed.

    Step in the Ventrassist and if they can manage to add the TETS then it will become the number 1 company for LVAD's.

    Please do more research before you post such nonsense.
 
watchlist Created with Sketch. Add VCR (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.